NCT05812807 2026-03-04
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Alliance for Clinical Trials in Oncology
Phase 3 Recruiting
Clinical Trials
23 trialsNCT06958328 2026-02-02
LAP100
NRG Oncology
Phase 3 Recruiting
NCT03180268 2026-01-14
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
NRG Oncology
Phase 3 Recruiting
NCT05717166 2025-12-31
SABR-SYNC
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 3 Recruiting
NCT03721341 2025-09-18
SABR-COMET 10
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 3 Active not recruiting
NCT03723941 2024-08-01
ACACIA
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Phase 3 Completed
NCT02355379 2024-07-08
ADAGE
Federation Francophone de Cancerologie Digestive
Phase 3 Recruiting
NCT06313567 2024-07-08
Metronomic Capecitabine in Stage III Gastric Cancer
Fudan University
Phase 3 Recruiting
NCT02109146 2024-05-29
Postoperative TACE(Transhepatic Arterial Chemotherapy And Embolization) for Patients With Hepatocellular Carcinoma
Zhejiang University
Phase 3 Completed
NCT03469674 2023-10-11
PORTEC-4a
Leiden University Medical Center
Phase 3 Active not recruiting
NCT00548756 2023-06-07
Randomized Trial Comparing Radiosurgery With vs Without Whole Brain Radiotherapy
M.D. Anderson Cancer Center
Phase 3 Completed
NCT05524389 2022-11-23
Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions
Peking Union Medical College Hospital
Phase 3 Not yet recruiting
NCT02063685 2022-06-21
Study to Evaluate the Efficacy of Response-adapted Strategy in Follicular Lymphoma
Fondazione Italiana Linfomi - ETS
Phase 3 Completed
NCT03199989 2020-03-06
EPAC1
Peking University Cancer Hospital & Institute
Phase 3 Unknown
NCT00300586 2019-05-28
IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung Cancer
Hospices Civils de Lyon
Phase 3 Completed
NCT00870701 2018-08-22
Observation Versus Post-surgery Radiotherapy After Complete Exeresis in Soft Tissues Members Sarcoma
Institut Claudius Regaud
Phase 3 Terminated
NCT00921414 2018-04-27
Mantel Cell Lymphoma Efficacy of Rituximab Maintenance
French Innovative Leukemia Organisation
Phase 3 Completed
NCT03016000 2017-07-28
Thalidomide Maintenance Treatment in DLBCL
Nanfang Hospital, Southern Medical University
Phase 3 Unknown
NCT00537199 2016-05-13
OraTest in Combination With Visual Examination and Visual Examination Alone
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT00004196 2014-01-20
Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis
University of Alabama at Birmingham
Phase 3 Completed
NCT00442637 2013-12-12
CAIRO3
Dutch Colorectal Cancer Group
Phase 3 Unknown
NCT01301560 2011-02-23
Chemotherapy With or Without Radiosurgery for Asymptomatic Oligo Brain Metastasis
Samsung Medical Center
Phase 3 Unknown
NCT00189631 2005-12-08
UFT/LV Maintenance Vs Observation in Metastatic Breast Cancer Responsive to Chemotherapy
Association Européenne de Recherche en Oncologie
Phase 3 Unknown